Synthesis and structure-activity relationships of small-molecular di-basic esters, amides and carbamates as flaviviral protease inhibitors

被引:4
|
作者
Sundermann, Tom R. [1 ,2 ]
Benzin, Clarissa, V [1 ]
Drazic, Tonko [1 ]
Klein, Christian D. [1 ]
机构
[1] Heidelberg Univ, Med Chem, IPMB, Neuenheimer Feld 364, D-69120 Heidelberg, Germany
[2] Univ Hosp Heidelberg, Inst Forens & Traff Med, Vossstr 2, D-69115 Heidelberg, Germany
关键词
Flavivirus; Dengue; Protease; Covalent-reversible inhibition; Carbamate; Ester; VIRUS PROTEASE; DENGUE; DISCOVERY;
D O I
10.1016/j.ejmech.2019.05.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibitors of the flaviviral serine proteases, which are crucial for the replication of dengue and West-Nile virus, have attracted much attention over the last years. A dibasic 4-guanidinobenzoate was previously reported as inhibitor of the dengue protease with potency in the low-micromolar range. In the present study, this lead structure was modified with the intent to explore structure-activity relationships and obtain compounds with increased drug-likeness. Substitutions of the guanidine moieties, the aromatic rings, and the ester with other functionalities were evaluated. All changes were accompanied by a loss of inhibition, indicating that the 4-guanidinobenzoate scaffold is an essential element of this compound class. Further experiments indicate that the target recognition of the compounds involves the reversible formation of a covalent adduct. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 50 条
  • [21] Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 protease.
    Abbenante, G
    Bergman, DA
    Brinkworth, RI
    March, DR
    Reid, RC
    Hunt, PA
    James, IW
    Dancer, RJ
    Garnham, B
    Stoermer, ML
    Fairlie, DP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (21) : 2531 - 2536
  • [22] Hologram quantitative structure-activity relationships for a class of inhibitors of HIV-1 protease
    Ferreira, Leonardo G.
    Leitao, Andrei
    Montanari, Carlos A.
    Andricopulo, Adriano D.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (05) : 356 - 364
  • [23] Molecular recognition by acetylcholinesterase at the peripheral anionic site: Structure-activity relationships for inhibitions by aryl carbamates
    Lin, GL
    Lai, CY
    Liao, WC
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (12) : 2683 - 2689
  • [24] Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease
    Nie, Shenyou
    Yao, Yuan
    Wu, Fangrui
    Wu, Xiaowei
    Zhao, Jidong
    Hua, Yuanda
    Wu, Jingyu
    Huo, Tong
    Lin, Yi-Lun
    Kneubehl, Alexander R.
    Vogt, Megan B.
    Ferreon, Josephine
    Rico-Hesse, Rebecca
    Song, Yongcheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (05) : 2777 - 2800
  • [25] Ketamine esters and amides as short-acting anaesthetics: Structure-activity relationships the side-chain
    Dimitrov, Ivaylo V.
    Harvey, Martyn G.
    Voss, Logan J.
    Sleigh, James W.
    Bickerdike, Michael J.
    Denny, William A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (07) : 1226 - 1231
  • [26] Synthesis and structure-activity relationships of USP48 deubiquitinylase inhibitors
    Boehm, Kevin
    Schulze-Niemand, Eric
    Kaehne, Thilo
    Siddiqui, Elisa
    Taeger, Christian
    Ramsbeck, Daniel
    Buchholz, Mirko
    Naumann, Michael
    ARCHIV DER PHARMAZIE, 2023, 356 (07)
  • [27] Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD
    Strancar, K
    Blanot, D
    Gobec, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) : 343 - 348
  • [28] The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors
    Steinman, DH
    Curtin, ML
    Garland, RB
    Davidsen, SK
    Heyman, HR
    Holms, JH
    Albert, DH
    Magoc, TJ
    Nagy, IB
    Marcotte, PA
    Li, JL
    Morgan, DW
    Hutchins, C
    Summers, JB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (16) : 2087 - 2092
  • [29] New indole derivatives as ACAT inhibitors: Synthesis and structure-activity relationships
    Bellemin, R
    Decerprit, J
    Festal, D
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (02) : 123 - 132
  • [30] Design, synthesis and structure-activity relationships of tetrahydroquinoline farnesyltransferase inhibitors.
    Lombardo, LJ
    Bhide, R
    Camuso, A
    Clark, J
    Fager, K
    Gullo-Brown, J
    Hunt, JT
    Inigo, I
    Kan, D
    Lee, F
    Manne, V
    McGlinchey, K
    Qian, LG
    Ricca, C
    Rovnyak, G
    Sheng, C
    Traeger, S
    Williams, D
    Wu, L
    Yang, J
    Zhao, YF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U174 - U175